Nanotherapeutics for treating coronavirus diseases
Viral diseases have recently become a threat to human health and rapidly become a significant cause of mortality with a continually exacerbated unfavorable socio-economic impact. Coronaviruses, including severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome (MERS...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Published: |
Elsevier
2021
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/26570/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.um.eprints.26570 |
---|---|
record_format |
eprints |
spelling |
my.um.eprints.265702022-03-18T08:23:16Z http://eprints.um.edu.my/26570/ Nanotherapeutics for treating coronavirus diseases Gunathilake, Thennakoon M. Sampath U. Ching, Yern Chee Uyama, Hiroshi Chuah, Cheng Hock QD Chemistry RM Therapeutics. Pharmacology TP Chemical technology Viral diseases have recently become a threat to human health and rapidly become a significant cause of mortality with a continually exacerbated unfavorable socio-economic impact. Coronaviruses, including severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome (MERS-CoV), and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), have threatened human life, with immense accompanying morbidity rates; the COVID-19 (caused by SARS-CoV-2) epidemic has become a severe threat to global public health. In addition, the design process of antiviral medications usually takes years before the treatments can be made readily available. Hence, it is necessary to invest scientifically and financially in a technology platform that can then be quickly repurposed on demand to be adequately positioned for this kind of pandemic situation through lessons learned from the previous pandemics. Nanomaterials/nanoformulations provide such platform technologies, and a proper investigation into their basic science and biological interactions would be of great benefit for potential vaccine and therapeutic development. In this respect, intelligent and advanced nano-based technologies provide specific physico-chemical properties, which can help fix the key issues related to the treatments of viral infections. This review aims to provide an overview of the latest research on the effective use of nanomaterials in the treatment of coronaviruses. Also raised are the problems, perspectives of antiviral nanoformulations, and the possibility of using nanomaterials effectively against current pandemic situations. Elsevier 2021-08 Article PeerReviewed Gunathilake, Thennakoon M. Sampath U. and Ching, Yern Chee and Uyama, Hiroshi and Chuah, Cheng Hock (2021) Nanotherapeutics for treating coronavirus diseases. Journal of Drug Delivery Science and Technology, 64. ISSN 1773-2247, DOI https://doi.org/10.1016/j.jddst.2021.102634 <https://doi.org/10.1016/j.jddst.2021.102634>. 10.1016/j.jddst.2021.102634 |
institution |
Universiti Malaya |
building |
UM Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Universiti Malaya |
content_source |
UM Research Repository |
url_provider |
http://eprints.um.edu.my/ |
topic |
QD Chemistry RM Therapeutics. Pharmacology TP Chemical technology |
spellingShingle |
QD Chemistry RM Therapeutics. Pharmacology TP Chemical technology Gunathilake, Thennakoon M. Sampath U. Ching, Yern Chee Uyama, Hiroshi Chuah, Cheng Hock Nanotherapeutics for treating coronavirus diseases |
description |
Viral diseases have recently become a threat to human health and rapidly become a significant cause of mortality with a continually exacerbated unfavorable socio-economic impact. Coronaviruses, including severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome (MERS-CoV), and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), have threatened human life, with immense accompanying morbidity rates; the COVID-19 (caused by SARS-CoV-2) epidemic has become a severe threat to global public health. In addition, the design process of antiviral medications usually takes years before the treatments can be made readily available. Hence, it is necessary to invest scientifically and financially in a technology platform that can then be quickly repurposed on demand to be adequately positioned for this kind of pandemic situation through lessons learned from the previous pandemics. Nanomaterials/nanoformulations provide such platform technologies, and a proper investigation into their basic science and biological interactions would be of great benefit for potential vaccine and therapeutic development. In this respect, intelligent and advanced nano-based technologies provide specific physico-chemical properties, which can help fix the key issues related to the treatments of viral infections. This review aims to provide an overview of the latest research on the effective use of nanomaterials in the treatment of coronaviruses. Also raised are the problems, perspectives of antiviral nanoformulations, and the possibility of using nanomaterials effectively against current pandemic situations. |
format |
Article |
author |
Gunathilake, Thennakoon M. Sampath U. Ching, Yern Chee Uyama, Hiroshi Chuah, Cheng Hock |
author_facet |
Gunathilake, Thennakoon M. Sampath U. Ching, Yern Chee Uyama, Hiroshi Chuah, Cheng Hock |
author_sort |
Gunathilake, Thennakoon M. Sampath U. |
title |
Nanotherapeutics for treating coronavirus diseases |
title_short |
Nanotherapeutics for treating coronavirus diseases |
title_full |
Nanotherapeutics for treating coronavirus diseases |
title_fullStr |
Nanotherapeutics for treating coronavirus diseases |
title_full_unstemmed |
Nanotherapeutics for treating coronavirus diseases |
title_sort |
nanotherapeutics for treating coronavirus diseases |
publisher |
Elsevier |
publishDate |
2021 |
url |
http://eprints.um.edu.my/26570/ |
_version_ |
1735409429613903872 |
score |
13.211869 |